3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Barrett Esophagus
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Lung Diseases
1
Hypoxia
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma
1
Breast Neoplasm Female
1
Adenocarcinoma of Lung
1
Interventions
Carboplatin
158
Paclitaxel
152
Bevacizumab
85
Gemcitabine
48
liposomal doxorubicin
47
Taxes
47
Topotecan
41
Cisplatin
34
pembrolizumab
33
Cyclophosphamide
27
olaparib
25
Immunoglobulin G
24
Disulfides
24
Specimen Handling
20
Docetaxel
20
Drug Therapy
19
Magnetic Resonance Spectroscopy
17
niraparib
16
Doxorubicin
16
Biopsy
15
mirvetuximab soravtansine
14
Hyperthermic Intraperitoneal Chemotherapy
13
rucaparib
12
Nivolumab
12
Cytoreduction Surgical Procedures
10
Albumin-Bound Paclitaxel
10
veliparib
9
Platinum
9
Chemotherapy, Adjuvant
9
130-nm albumin-bound paclitaxel
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Fallopian Tube Neoplasms
×
Diagnostic Imaging
×
Clear all
NCT04001023
2019-08-07
OVANOX
Turku University Hospital
Phase NA
Unknown
40 enrolled